Protagonist Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Protagonist Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Protagonist Therapeutics Inc
Rating: 1.93100
Author: Trendlyne DVM scores

about

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology,...

92.09 0.68 (0.74%)

Near 52W High of $96.54

571.4K

XNAS Volume

XNAS 06 Mar, 2026 4:30 PM (EST)

Board Meeting

The next board meeting for Protagonist Therapeutics Inc is on 12 Mar 2026 for the purpose of Barclays 28th Annual Global Healthcare Conference See details